Phase II Study of Cabozantinib in Patients With Bone Metastasis

Bone metastases are often difficult to manage as they can be symptomatic and skeletal-related events (SREs) can contribute to significant morbidity and declines in performance status. We sought to identify a novel medical treatment for bone metastasis by testing the safety and efficacy of cabozantin...

Descripción completa

Detalles Bibliográficos
Autores principales: Choy, Edwin, Cote, Gregory M, Michaelson, M Dror, Wirth, Lori, Gainor, Justin F, Muzikansky, Alona, Sequist, Lecia V, Sullivan, Ryan J, Fidias, Panagiotis M, Shaw, Alice, Heist, Rebecca S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Sarcomas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256024/
https://www.ncbi.nlm.nih.gov/pubmed/35524758
http://dx.doi.org/10.1093/oncolo/oyac083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256024/
https://www.ncbi.nlm.nih.gov/pubmed/35524758
http://dx.doi.org/10.1093/oncolo/oyac083

Ejemplares similares